Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Antibody binding alpha4Beta7 integrin and its use to treat inflammatory bowel disease
No-Receipt date
2017-00011 - 03/01/2017
No-Filing date
20170400012 - 03/01/2017
No-Granting date
3091200 - 08/03/2017
No-EPO application date
10010997.4 - 13/04/2001
No-EPO granting date
2298348 - 12/10/2016
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
3/2017 - 15/05/2017
Expiration date
14/04/2021
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US55008214/04/2000/US
US74896027/12/2000/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/52
A61K 31/57
A61K 31/60
A61K 31/635
A61K 39/395
A61P 37/06
Related Documents
Related Titles
Type
Master title
Related title
[SPC]
20170800015
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
725153
MILLENNIUM PHARMACEUTICALS, INC.
40 LANDSDOWNE STREET
CAMBRIDGE, MA 02139
UNITED STATES OF AMERICA (USA)
725154
GENENTECH, INC.
1 DNA WAY
SOUTH SAN FRANCISCO, CA 94080-4990
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
1777393
BRETTMAN, LEE R.
1777394
FOX, JUDITH A.
1777395
ALLISON, DAVID EDWARD
Representatives
Code
Firstname
Surname
Address
Town
Zip
3458
ELENI
PAPAKONSTANTINOU "ELENI G. PAPAKOSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
8784
ELENI
PAPAKONSTANTINOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
5/10/2021 12:00:00 AM
Λήξη Προστασίας Τίτλων (79600)
79600
Payments history
20 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).